UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.10% of ...

BEIJING, Sept. 27 (Xinhua) -- China's central bank on Friday cut the reserve requirement ratio (RRR) for financial institutions by 0.5 percentage points and lowered the seven-day reverse repo interest ...

Only 3.0% of CFOs said their companies were spending on new AI capabilities. Despite rate cuts, only 7.0% projected an ...

London’s Mandarin Oriental played host on Thursday to the second successful Euromoney Foreign Exchange Awards, with more than ...

A Swiss brokerage has warned that fiscal profligacy in states approaching elections could affect capital expenditure. The report by UBS Securities highlighted that Maharashtra, Madhya Pradesh, ...

On Thursday, Chemours Co (CC) stock saw a modest uptick, ending the day at $20.8 which represents a slight increase of $2.11 or 11.29% from the prior close of $18.69. The stock opened at $19.35 and ...

Friday's edition of Forbes Daily covers Eric Adams' charges, China boosts U.S. stocks, the world's richest woman, a ...

There's a newly approved drug for schizophrenia from Bristol Myers Squibb.

Singapore is steaming ahead as Asia’s most proficient wealth management hub, but Hong Kong is expected to catch up once China ...

There is a clear winner between these two companies trying to capitalize on the growing demand for AI graphics cards.